Group

The market is experiencing steady growth driven by rising prevalence of autoimmune and inflammatory conditions, increasing healthcare expenditure, and rapid advancements in biologic therapies. Growing awareness of rare dermatological disorders and rising initiatives by public and private organizations to improve diagnosis are further fueling expansion. The increasing adoption of targeted immunotherapies, rising demand for effective wound management solutions, and growing R&D activities focused on launching novel biologics are creating beneficial opportunities.